The federal
government plans to give children – possibly millions of them – a live influenza vaccine they could transmit to anyone with whom they come into contact.
The vaccinations could start as early as a few weeks from now, and the infections could be spread for up to three weeks following the vaccinations, officials confirmed.
Each half milliliter portion of the formula, called FluMist, contains particles of “live, attenuated influenza virus,” writes Robert Carrillo on his extensive blog posting about the vaccine.
“That means that between 10 million and 100 million viral particles will be forcefully injected into the nostrils administered,” he says.
Carillo warns one of the most troubling concerns over the injection is the potential for the viruses to enter directly into the brain.
“At the top of the nasal passages is a paper-thin bone called the cribriform plate,” he explains. “The olfactory nerves pass through this bone and line the nasal passages, carrying messenger molecules to the brain that are identified as ’smells’ familiar to us. The olfactory tract has long been recognized as a direct pathway to the brain.”
According to MedImmune, the company providing FluMist, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted earlier this year to “expand flu vaccination recommendations to include all children six months through 18 years of age.”
Previously, the recommendations were to vaccinate children from six months to 59 months of age, the report said.
“The new guidelines add approximately 30 million children to the recommended pediatric population to be vaccinated annually against influenza,” the company said.
“MedImmune is committed to doing all it can to support the ACIP’s expanded influenza vaccination recommendations and to work toward our common goal to vaccinate more children against the flu each year,” John Trizzino, vice president, vaccines, said in a prepared statement. “The data presented … highlight the need to use every possible opportunity to improve vaccination rates and compliance, including vaccinating children when they visit their healthcare providers for back-to-school check-ups and sports physicals. We are focused on delivering FluMist(R) (Influenza Virus Vaccine Live, Intranasal) into the marketplace this year beginning in August.”
Carrillo, who works with an organization advising about the dangers of vaccines, says among some of the ingredients of various vaccines are human diploid lung cells, fetal bovine serum, aluminum, formaldehyde, mercury and dry natural latex rubber.
In this particular case, however, probably the most significant issues are that recipients of the vaccine could suffer complications. There are advisories against giving it to children under age 2, anyone with asthma or pregnant women, and the vaccine could transmit the virus itself to others.
“It has been documented that the live viruses from the vaccine can be shed (and potentially spread into the community) from recipient children for up to 21 days,” Carrillo writes.
Dr. Jane Orient, executive director of the Association of American Physicians and Surgeons, agreed.
“It’s a live virus,” she told WND. “There is a risk if you give it to a child, the child could expose someone to that vaccine virus in whom there could be complications.”
The drug manufacturer also warns of possible complications for people afflicted with the Guillain-Barre syndrome.
“You could transmit the virus [to someone] in whom the vaccine could cause a reaction,” Orient said. “What about a child whose mother turns out to be pregnant?”
There also is a warning about the danger to people whose immune systems are affected, such as individuals taking chemotherapy.
A study cited by the company in its documentation about the vaccine confirmed that a transmission of influenza from a vaccinated child to someone else is possible. That study encompassed 197 children in a day-care center, officials said.
“It does replicate and is shed and has been transmitted to a few individuals in this study,” Orient said.
But she said that going from 197 children to 30 million kids, “I would say is a big experiment.”
“I would be concerned about the hazards,” she told WND. “And I’m not convinced about the benefit.”
Orient, who serves as medical adviser for the institute’s projects involving human health and disease, also is president of Doctors for Disaster Preparedness and of Physicians for Civil Defense.